Seedy19
@seedy19tron
Biotech • L/S investing • Tweets are not investment advice
$Abvx (Long) Ph3 topline for Obe coming up. Exp early to mid Aug $abvx is also my biopickcontest pick (if it hits could be a multi bagger) and now waiting on 8-week induction data to confirm Obe as a standout oral drug.
(Corrected*) $abvx offering priced at $64, $650m (upsized), ~10.2m shares Recent great data being rewarded comp: $IMGN offering $12.5 -> 6 mon $31.2 +150% $RXDX offering $110 -> 4 mon $200 +81%

Ph3 hit , there will be many suitors lining up for $abvx For ref M&A/ deals in IBD last 5 year alone…
The buyout rumor that $ABVX had a suitor years ago (which appears to be true) is covered the main document I attached to the pitch thread! docs.google.com/document/d/1NI…